RuleMedi
Catalyst
Regulatory Foresight. Strategic Advantage.
Catalyst is the anticipatory intelligence engine of RuleMedi. It scans the global regulatory horizon for signals that will affect your device portfolio, predicts their impact before they become obligations, and provides the strategic foresight to act decisively — not reactively.
From Horizon to Action
Catalyst transforms the overwhelming volume of regulatory intelligence into a prioritised, actionable signal. It is the difference between being surprised by a regulatory change and being prepared for it months in advance.
Regulatory Horizon Scanning
Catalyst continuously monitors regulatory pipelines across EU, UK, and international bodies — tracking proposed legislation, guidance consultations, SCENIHR opinions, and MDCG guidance — so you are never surprised by a regulatory change.
Portfolio Impact Prediction
When a regulatory change is detected, Catalyst maps its predicted impact across your specific device portfolio, identifying which products, Technical Documentation sections, and clinical evidence packages will be affected.
Weak Signal Detection
Catalyst detects early-stage signals — enforcement trends, Notified Body audit findings, SCCS opinions, and post-market safety signals — before they crystallise into formal regulatory requirements, giving you a decisive head start.
Strategic Compliance Roadmapping
Translate horizon intelligence into actionable strategic roadmaps. Catalyst generates prioritised, time-bound compliance roadmaps that feed directly into Conductor’s workflow engine, closing the loop from intelligence to execution.
Monitoring Every Signal That Matters
Catalyst monitors a comprehensive range of regulatory intelligence sources across the EU and UK, synthesising them into a coherent, prioritised view of what is changing and what it means for your business.
- EU MDR/IVDF implementing acts and delegated regulations
- MDCG guidance documents and position papers
- MHRA guidance updates and UK statutory instruments
- Notified Body audit finding trends
- SCENIHR and SCCS scientific committee opinions
- EMA/MHRA pharmacovigilance and safety signal trends
- International standards updates (ISO 13485, ISO 14971, IEC 62304)
- Emerging enforcement actions and market withdrawals
Stop Reacting. Start Anticipating.
Catalyst gives your regulatory leadership the intelligence to make proactive, evidence-based decisions — turning regulatory foresight into a genuine competitive advantage.